LoJack Corporation (NASDAQ:LOJN) shares remains unchanged in last trading session and ended the day at $6.44. LOJN Gross Margin is 54.40% and its has a return on assets of 4.40%. LoJack Corporation (NASDAQ:LOJN) quarterly performance is 23.14%.
On Mar 18, CalAmp Corp. (NASDAQ: CAMP) (“CalAmp”) and LoJack Corporation (NASDAQ:LOJN) announced the expiration of the subsequent offering period of the cash tender offer by CalAmp’s wholly-owned subsidiary, Lexus Acquisition Sub, Inc. (“Purchaser”), for all of the outstanding shares of common stock of LoJack at a price of $6.45 per share, net to the seller in cash, without interest and less any applicable withholding taxes.
The Hanover Insurance Group, Inc. (NYSE:THG) ended the last trading day at $86.82. Company weekly volatility is calculated as 1.37% and price to cash ratio as 10.97. The Hanover Insurance Group, Inc. (NYSE:THG) showed a weekly performance of 1.75%.
he Hanover Insurance Group, Inc. (NYSE:THG) announced that its board of directors declared a quarterly dividend of $0.46 per share on the issued and outstanding common stock of the company, payable March 25, 2016, to shareholders of record at the close of business onMarch 11, 2016.
On 22 March, Financial Institutions Inc. (NASDAQ:FISI) shares decreased -1.04% and was closed at $28.49. FISI EPS growth in last 5 year was 3.40%. Financial Institutions Inc. (NASDAQ:FISI) year to date (YTD) performance is 1.75%.
Resonant Inc. (NASDAQ:RESN) shares decreased -5.56% in last trading session and ended the day at $3.06. RESN has a return on assets of -73.70%. Resonant Inc. (NASDAQ:RESN) quarterly performance is 16.79%.
Resonant Inc. (NASDAQ: RESN), announced it will release financial results for the fourth quarter and year ended December 31, 2015, after market close on Wednesday, March 23, followed by an investor conference call at 1:30 p.m. PDT/4:30 p.m. EDT. Chief Executive Officer Terry Lingren and Chief Financial Officer John Philpott will host the call.
Stemline Therapeutics, Inc. (NASDAQ:STML) caters to the Healthcare space. weekly performance is -4.85%. On the last day of trading company shares ended up at $4.90. Stemline Therapeutics, Inc. (NASDAQ:STML) distance from 50-day simple moving average (SMA50) is 5.78%.
On March 14, Stemline Therapeutics, Inc. (NASDAQ:STML) reported financial results for the quarter ended December 31, 2015.Stemline ended the fourth quarter of 2015 with $97.5 million in cash, cash equivalents and investments, as compared to $104.0 million as of September 30, 2015, which reflects a cash burn of $6.5 million for the quarter. The company ended the fourth quarter of 2015 with 18.2 million shares outstanding.
Leave a Reply